Veterinary Practice Succession Planning: The 5-Year Exit Roadmap

Most vet practice owners think about succession when they're already burned out — which is the worst time to start. A practice exit is one of the largest financial transactions of your life. The owners who get the best outcomes start planning 5–10 years early, not 5 months. This guide covers what the timeline actually looks like, how the exit paths differ financially, and what moves to make — and when — to maximize what you walk away with.

Why Succession Planning Is Different From Just "Selling"

Succession planning isn't just about the transaction. It's about positioning the practice so it can operate without you — which is what makes it valuable to any buyer and what determines whether you get $2.5M or $4.5M for the same underlying practice.

A practice that depends on the owner-DVM for client relationships, for clinical oversight, for staff management, and for culture is worth less than one that runs on systems. Corporate consolidators, sophisticated private buyers, and associate buy-in candidates all discount heavily for owner-dependence — sometimes by 2–3× EBITDA. The goal of succession planning is to systematically reduce that dependency before the sale clock starts.

The Three Exit Paths (and How They Compare)

1. Internal Succession: Associate Buy-In

You sell equity to an associate DVM already working in the practice — either in full at once (if they have financing) or in tranches over 3–7 years. This is often the cleanest transition for continuity and staff retention because the new owner is a known quantity.

Typical structure: The associate purchases equity using an SBA 7(a) loan, seller financing, or a combination. SBA 7(a) currently lends up to $5M with 10-year terms at variable rates (prime + 2.75% maximum). Seller financing often covers the gap between what SBA will lend and the full purchase price, typically at 4–6% over 5–7 years.

Financial trade-off: You'll generally receive 4–6× normalized EBITDA — the same range as any private buyer. The advantage isn't price; it's certainty and control. You negotiate transition terms without a corporate intermediary, you choose who carries on your practice culture, and the earnout/employment period can be shorter or more flexible.

See also: Associate Buy-In: Is Equity Worth It? (written from the associate's perspective) and Vet Practice Valuation for how to establish the equity price.

2. Private Sale to an Outside Buyer

You list the practice with a broker (Simmons, USPVS, or regional specialists) or find a buyer directly. The purchaser is typically an individual DVM or a small group. SBA financing dominates this market, which caps how high buyers can bid — debt service coverage constraints limit most SBA-financed buyers to 4–6× EBITDA on the total price.

Key considerations: Outside buyers don't know your staff, clients, or workflows. A longer transition period (6–24 months) is standard and often required by lenders. Non-compete agreements in private sales typically run 3–5 years in your geographic radius. Pricing negotiations involve an independent broker appraisal, and the buyer's lender will order their own valuation.

3. Corporate Sale (Mars, NVA, MVP, Southern Veterinary Partners)

Corporate consolidators offer the highest purchase prices — typically 8–14× EBITDA for qualifying practices — but the structure is more complex. Cash at close is usually 60–80% of total consideration; the rest is equity rollover (5+ year lockup in the acquiring platform) and earnout tied to performance targets.

Financial considerations: A 10× EBITDA offer that's 65% cash at close and 35% equity rollover is really a 6.5× cash deal plus an illiquid 3.5× bet on the platform's PE exit. If the platform fails to sell at a premium multiple — or sells in a down market — that equity rollover can be worth significantly less than the paper value.

See also: Corporate Offer Analysis and the Corporate Offer Calculator for after-tax modeling of specific deal terms.

The 5-Year Succession Timeline

5 Years Out: Baseline and Positioning

• Get a preliminary valuation. You need to know your starting point — not a guess, a real EBITDA normalization exercise. See Vet Practice Valuation for the methodology. A broker or advisor can do a draft opinion of value for free or low cost as part of a planning engagement.
• Start normalizing financials. Five years of clean, normalized financials will significantly strengthen your exit position. This means consistent, market-rate owner compensation (don't overpay yourself on paper or underpay on paper), documented add-backs, and no co-mingling of personal and business expenses.
• Maximize pre-tax retirement contributions. If you're 5 years out, this is peak contribution time. A solo 401(k) plus a cash balance plan can shelter $150–350K/year from taxes for high-income practice owners. At the 37% bracket, that's $55K–$130K in annual tax savings — compounded over 5 years before the exit. See Veterinarian Retirement Planning for specifics.
• Identify your successor or buyer type. If internal succession is the plan, the associate candidate should be identified and, ideally, beginning to build client relationships now — not scrambling at year 4.

3 Years Out: Value Maximization

• Reduce owner-dependence. Systems matter more than individual effort at this stage. Document clinical protocols, delegate management functions to a practice manager, build the associate staff so revenue isn't tied to your hours. Every hour of revenue that flows through non-owner DVMs makes the practice more transferable.
• Invest in EBITDA-positive improvements. Equipment that increases capacity or reduces staff cost has a positive ROI at a 6× multiple — spend $100K on a new digital radiography system with 6× EBITDA impact and you get $600K in enterprise value. Spend $100K on a lobby remodel and you get $100K (maybe) in perceived value. Focus capital on revenue or margin.
• Build a management layer. A practice manager and/or a lead DVM who can handle day-to-day clinical oversight is one of the highest-value investments you can make for a sale. It concretely answers the buyer's first question: what happens if the owner doesn't show up?
• Begin talking to advisors. At 3 years, it's the right time to engage a veterinary practice broker for a formal opinion of value, a CPA who knows veterinary transactions to review your tax structure, and a financial advisor who specializes in large-asset liquidity events to model the post-sale picture.

1–2 Years Out: Structure and Pre-Sale Planning

• Choose your exit path and engage the right intermediary. Corporate sale → engage a vet-focused M&A advisor who regularly represents sellers. Private sale → list with a practice broker or run a controlled auction among a known buyer pool. Internal succession → negotiate directly with your associate, with attorney and CPA on both sides.
• Pre-sale tax planning. This is time-sensitive. Installment sale elections, pre-sale Roth conversions, charitable vehicles (DAF, CRT) to absorb capital gains, and pre-sale S-corp restructuring if applicable all need to be in place before the LOI. The wrong transaction structure can cost 5–10% of the sale price in unnecessary taxes. See Selling a Vet Practice: Tax Guide for the full breakdown.
• Address key person and practice continuity risk. Life insurance on yourself (key person policy payable to the practice) and a buy-sell agreement with any partners should be in place. If you have a key associate who is critical to revenue, consider a retention agreement tied to the sale. Buyers will scrutinize key-person dependency.
• Review and clean up leases, equipment loans, and contracts. Assignability of your practice lease is critical — many buyers discover at closing that the landlord has consent rights. Service contracts, vendor agreements, and employment agreements with key staff should all be reviewed for assignability and change-of-control provisions.

At the LOI: Negotiation and Due Diligence

Once you receive a letter of intent, the buyer (or their lender) will conduct financial and operational due diligence. This typically runs 60–120 days for a corporate deal, 30–90 days for a private or SBA-financed deal. The due diligence process reviews 3 years of tax returns and P&Ls, payroll records, equipment lists, lease terms, patient counts, and staff turnover. Clean financials and organized documentation accelerate this process and reduce renegotiation risk.

The most common reasons deals fall apart or reprice at close:

• Revenue concentration: one veterinarian driving 60%+ of production signals key-person risk
• Undisclosed lease problems: landlord won't assign, or lease expires in <3 years
• Normalized EBITDA that doesn't hold up under scrutiny (add-backs the buyer disputes)
• Staff turnover or known departures post-announcement
• Equipment that's older than represented or has unaddressed deferred maintenance

The Employment Agreement: What Happens After the Sale

For corporate deals and most private transactions, the selling DVM is expected to stay and work for a transition period — typically 1–3 years. The terms of this employment agreement are negotiable and meaningfully affect your total economics:

• Compensation: Post-sale salaries vary widely — $160K–$250K W-2 for a full-time DVM is typical. If your agreement is production-based, understand what percentage of your collections stays as compensation.
• Non-compete: Corporate buyers typically require a 5-year, 20-mile non-compete upon expiration of the employment period. The enforceability depends on state law, but assume it's real. If you plan to work in veterinary medicine after the lockout period, negotiate the radius and duration carefully.
• Earnout terms: If your deal includes an earnout tied to revenue targets, understand what the targets are relative to current run rate, what you control and don't control post-close, and what happens if the corporate entity changes management or reduces staff.

Who You Need on Your Team

A practice exit at $2M+ is too large and too complex to navigate without advisors. The minimum team:

• Veterinary practice broker or M&A advisor: Knows market multiples, runs the process (for corporate deals especially), and negotiates on your behalf. National firms (Simmons, Henry Schein) or boutique vet-specific advisory shops. Fee: typically 3–5% of transaction value.
• CPA with veterinary transaction experience: Asset vs. stock sale election, allocation of purchase price among asset classes, installment sale structuring, and the tax return that captures the entire transaction correctly. A generalist CPA who has never done a veterinary practice sale is a liability here.
• Transaction attorney: Reviews and negotiates the purchase agreement, employment agreement, non-compete, and any representation and warranty provisions. This is a different engagement than your regular business attorney.
• Financial advisor (fee-only, large-asset liquidity specialist): Models the post-sale picture — invested assets, IRMAA exposure, Roth conversion windows, charitable planning, and how the liquid proceeds integrate with any remaining retirement accounts. The advisor earns their fee most visibly in the year of the sale and the 2 years after, when every major financial decision concentrates.

Get matched with a fee-only advisor who specializes in veterinary practice exits.

The Post-Sale Financial Picture

Most practice owners underestimate how different life looks financially after the sale. Key things to model in advance:

• Tax year of sale: A $3M practice sale in a single tax year (even with installment sale spreading) concentrates income. IRMAA surcharges on Medicare Part B and Part D kick in 2 years after the high-income year — meaning even if you retire, your Medicare premiums in years 2–3 post-sale can be $5,000–$14,000/year above base.
• The gap year(s): If you retire before Medicare eligibility at 65, you'll need private health insurance — which can run $20,000–$35,000/year for a couple not yet Medicare-eligible. ACA marketplace coverage has income cliffs at 400% of the federal poverty level; practice sale proceeds can push you well above the subsidy threshold.
• RMD timing: If you've aggressively sheltered income in a Solo 401(k) and cash balance plan, you may have $1.5M–$3M in pre-tax accounts that will generate Required Minimum Distributions starting at age 73 (for those born 1951–1959) or 75 (born 1960+) per SECURE 2.0.¹ Modeling the RMD schedule against your spending needs and tax bracket prevents surprises.
• Roth conversion window: The years between practice sale and age 73 (when RMDs start) are often the best window for Roth conversions — income is lower, pre-tax balances are still growing, and the tax cost of conversion is often lower than the tax cost of forced RMDs later.

Frequently Asked Questions

When is the right time to start succession planning?

Earlier than you think. Most advisors recommend 5–7 years as the ideal runway. At 3 years, you still have meaningful time to improve EBITDA and reduce owner-dependence, but your window for some strategies (building a management layer, cleaning up financials) starts to close. At 1 year, you're mostly in execution mode on a deal that's already largely defined by the practice you built.

What if I get an unsolicited corporate offer before I've planned?

Don't sign anything, and don't assume the first offer is the best offer. Corporate consolidators send unsolicited term sheets regularly — the first offer is rarely their best. Get your own advisor and broker on the phone first. Use the Corporate Offer Calculator to model the after-tax economics before reacting to the headline number.

Can I sell to multiple associates over time instead of all at once?

Yes — a phased equity sale is common in internal succession. You might sell 30% to an associate in year 1, retain 70% and a management role, then sell remaining equity 3–5 years later when the associate has proven revenue contribution and secured additional financing. The tax treatment of each tranche is separate. Your attorney and CPA need to structure the operating agreement to handle partial-ownership governance cleanly.

What if my practice isn't large enough to attract a corporate buyer?

Most corporate consolidators are interested in practices with $400K+ in normalized EBITDA. Practices below that threshold — which is most single-doctor practices — primarily sell in the private market or through internal succession. This isn't a failure of the practice; it's simply the market. At a 4–5× multiple on $200K EBITDA, a private sale still produces a $800K–$1M transaction — real money, but a different magnitude than a corporate deal.

1. IRS: Required Minimum Distributions (RMDs) — RMD age 73 (born 1951–1959) and 75 (born 1960+) per SECURE 2.0 § 107
2. SBA 7(a) Loan Program — terms and borrower requirements
3. IRS Topic No. 409: Capital Gains and Losses — LTCG rates applicable to practice sale proceeds
4. IRS: One-Participant 401(k) Plans — Solo 401(k) contribution limits and rules

Financial figures verified against 2026 IRS guidance and SBA program terms. EBITDA multiples reflect private market transaction data from veterinary practice brokers as of 2025–2026. Individual transactions vary based on practice size, location, growth profile, and buyer type. Consult a qualified advisor before making any exit planning decisions.